VYNE Therapeutics Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2014 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
VYNE Therapeutics Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2014 to Q4 2023.
  • VYNE Therapeutics Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $2.46M, a 13.9% decline year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $2.46M -$396K -13.9% Dec 31, 2023 10-K 2024-03-01
Q4 2022 $2.85M +$55K +1.97% Dec 31, 2022 10-K 2024-03-01
Q4 2021 $2.8M -$284K -9.21% Dec 31, 2021 10-K 2024-03-01
Q4 2020 $3.08M +$2.37M +332% Dec 31, 2020 10-K 2023-03-14
Q4 2019 $714K -$176K -19.8% Dec 31, 2019 10-K 2022-03-17
Q4 2018 $890K +$87K +10.8% Dec 31, 2018 10-K 2021-03-04
Q4 2017 $803K +$574K +251% Dec 31, 2017 10-K 2020-03-03
Q4 2016 $229K +$136K +146% Dec 31, 2016 10-K 2020-03-03
Q4 2015 $93K +$20K +27.4% Dec 31, 2015 10-K 2019-02-28
Q4 2014 $73K Dec 31, 2014 10-K 2018-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.